Doug Frandsen

Doug Frandsen serves as Corporate Controller and is responsible for financial accounting and reporting, budgeting, tax, and financial controls.

Mr. Frandsen brings nearly 20 years of financial expertise to his role at Emalex. Most recently, he served as U.S. Controller for Orphazyme. Prior to that, Mr. Frandsen held various finance and accounting roles of increasing responsibility at Baxter International, Baxalta, Shire Pharmaceuticals, and Takeda Pharmaceuticals over a series of corporate divestitures and acquisitions. He began his career in public accounting at Ernst & Young in Chicago.

Mr. Frandsen holds a Master of Accounting Science degree and a Bachelor of Accounting Science degree from the University of Illinois, Urbana-Champaign.